Stable chronic obstructive pulmonary disease.
作者信息
Kerstjens H A
机构信息
Department of Pulmonary Diseases, University Hospital Groningen, PO Box 30 001, 9700 RB Groningen, Netherlands.
出版信息
BMJ. 1999 Aug 21;319(7208):495-500. doi: 10.1136/bmj.319.7208.495.
Abstract
摘要
相似文献
1
Stable chronic obstructive pulmonary disease.
BMJ. 1999 Aug 21;319(7208):495-500. doi: 10.1136/bmj.319.7208.495.
2
Chronic obstructive pulmonary disease.
Clin Evid. 2006 Jun(15):2077-100.
3
[Management of patients with chronic obstructive pulmonary disease].
Rev Clin Esp. 1994 Dec;194(12):1049-57.
4
[Bronchodilator treatment of patients with COPD (1994)].
Rev Med Liege. 1994 Nov 1;49(11):593-5.
5
[Current approaches to the treatment of chronic obstructive pulmonary diseases].
Ter Arkh. 2003;75(8):83-7.
6
Chronic obstructive pulmonary disease.
Clin Evid. 2005 Jun(13):1923-47.
7
Chronic obstructive pulmonary disease.
Clin Evid. 2002 Dec(8):1530-45.
8
Combination bronchodilator therapy in COPD.
Chest. 1995 May;107(5 Suppl):171S-175S. doi: 10.1378/chest.107.5_supplement.171s.
9
Medicines for COPD.
Am J Respir Crit Care Med. 2019 Jul 15;200(2):P3-P5. doi: 10.1164/rccm.2002P3.
10
Acute exacerbations of COPD. How to evaluate severity and treat the underlying cause.
Postgrad Med. 1992 Jan;91(1):105-7, 110-2. doi: 10.1080/00325481.1992.11701168.
引用本文的文献
1
COPDGene 2019: Redefining the Diagnosis of Chronic Obstructive Pulmonary Disease.
Chronic Obstr Pulm Dis. 2019 Nov;6(5):384-399. doi: 10.15326/jcopdf.6.5.2019.0149.
2
Budesonide/formoterol: in chronic obstructive pulmonary disease.
Drugs. 2004;64(4):431-41; discussion 433-4. doi: 10.2165/00003495-200464040-00006.
3
Stable chronic obstructive pulmonary disease. Incomplete evidence based reviews may condemn by omission.
BMJ. 2000 Jan 29;320(7230):312; author reply 313.
本文引用的文献
1
Long term effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
Thorax. 1999 Jan;54(1):7-14. doi: 10.1136/thx.54.1.7.
2
Efficacy and safety of inhaled corticosteroids. New developments.
Am J Respir Crit Care Med. 1998 Mar;157(3 Pt 2):S1-53. doi: 10.1164/ajrccm.157.3.157315.
3
Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease. International COPD Study Group.
Lancet. 1998 Mar 14;351(9105):773-80. doi: 10.1016/s0140-6736(97)03471-5.
4
Routine nebulized ipratropium and albuterol together are better than either alone in COPD. The COMBIVENT Inhalation Solution Study Group.
Chest. 1997 Dec;112(6):1514-21. doi: 10.1378/chest.112.6.1514.
5
An evaluation of salmeterol in the treatment of chronic obstructive pulmonary disease (COPD).
Eur Respir J. 1997 Apr;10(4):815-21.
6
Adverse effects of corticosteroid therapy for COPD. A critical review.
Chest. 1997 Mar;111(3):732-43. doi: 10.1378/chest.111.3.732.
7
Quality of life changes in COPD patients treated with salmeterol.
Am J Respir Crit Care Med. 1997 Apr;155(4):1283-9. doi: 10.1164/ajrccm.155.4.9105068.
8
Risk factors for accelerated decline among patients with chronic obstructive pulmonary disease.
Am J Respir Crit Care Med. 1996 Dec;154(6 Pt 2):S266-72. doi: 10.1164/ajrccm/154.6_Pt_2.S266.
9
Longitudinal studies of air pollution effects on lung function.
Am J Respir Crit Care Med. 1996 Dec;154(6 Pt 2):S250-6. doi: 10.1164/ajrccm/154.6_Pt_2.S250.
10
Longitudinal analyses of airway responsiveness and pulmonary function decline.
Am J Respir Crit Care Med. 1996 Dec;154(6 Pt 2):S246-9. doi: 10.1164/ajrccm/154.6_Pt_2.S246.
Zotero 插件